Jennifer Cheng ’05 Appointed as Vice President and General Counsel of Adverum Biotechnologies, Inc.

Jennifer Cheng ’05 was appointed to serve as the vice president and general counsel of Adverum Biotechnologies, Inc. Cheng has served as vice president and associate general counsel of Adverum since February 2016, and previously served as the senior patent counsel, director of intellectual property of Adverum from June 2015 to February 2016. Prior to joining Adverum, she served as a patent counsel at Allergan plc, a global pharmaceutical company, from March 2013 to May 2015 and as the senior patent counsel at MAP Pharmaceuticals, a biotechnology company, from June 2011 until its acquisition by Allergan in March 2013. From August 2008 to May 2011, Dr. Cheng served as the manager of intellectual property at Solazyme, Inc., a biotechnology company, and previously was a patent counsel at Raven Biotechnologies, Inc., a biotechnology company. Dr. Cheng received a B.A. from the University of California, Berkeley, and a Ph.D. in tumor cell biology and molecular medicine from Northwestern University in addition to her J.D. from Santa Clara Law.